Eton Pharmaceuticals Inc. (ETON) to Resume Trading at 11:10 a.m.

Go back to Eton Pharmaceuticals Inc. (ETON) to Resume Trading at 11:10 a.m.

Eton Pharmaceuticals (ETON) Announces FDA Approval of Rezipres

June 15, 2021 10:38 AM EDT

Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres® (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.

We are excited to see... More